Study identifies therapeutic target for Alzheimer's disease, revealing strategy for preventing or slowing disease progression

A new study suggests a key protein molecule plays a major role in the accumulation of brain cholesterol, triggering the development of Alzheimer's and supporting the use of peptide inhibitors as a therapeutic treatment target. The study found that mice, when treated with the peptide inhibitor, demonstrated 50% restored memory function, based on testing such as navigating mazes.